The effects of empagliflozin on hepatic parameters and liver fat content in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Background: Type 2 Diabetes Mellitus (T2DM) often coexists with hepatic complications, including Non-Alcoholic Fatty Liver Disease (NAFLD), posing significant challenges in treatment strategies. Empagliflozin, a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor, has garnered attention for managing T...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2024
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://eprints.usm.my/62576/ |
| Abstract | Abstract here |